(Q77952222)

English

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis

scientific article published on 01 February 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

prostate cancer

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

E T Goluboff

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Shabsigh

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J A Saidi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

I B Weinstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

N Mitra

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Heitjan

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Pamukcu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Buttyan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C A Olsson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 February 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

440-445

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Current good manufacturing practices

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900513-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00513-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9933075%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77952222&oldid=1856241707"